Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-21-000144

EVP, Chief Financial Officer bought 3,000 shares at $37.46 ($112,380)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
LINDAHL RICHARD S EVP, Chief Financial Officer 2021-11-15 Purchase +3,000 $37.46 $112,380 39,919 D: show line 1 in the form
Open-market purchases · 3,000 sh · avg $37.46 · $112,380
Loading xslF345X03/wf-form4_163701676472498.xml…